Targeting BCL-2 and PI3K signaling pathways enhances cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cells

Biochemical and Biophysical Research Communications 2026 Open access

Read full text
Authors: Małgorzata Opydo‐Chanek, Malgorzata Wojtaszek, Aleksandra Mosurek, Gabriela Burczyk, Anna Such, Elżbieta Kołaczkowska
DOI: 10.1016/j.bbrc.2026.153752
Cited by: 1
References: 38

Fields of Study & Subjects

Cell death mechanisms and regulation PI3K/AKT/mTOR signaling in cancer Acute Myeloid Leukemia Research

Publication details

Journal / source
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Volume
817
Pages
153752–153752
Publication date
9 April 2026
Language
EN